Publicaciones en colaboración con investigadores/as de Johannes Gutenberg University of Mainz (13)

2020

  1. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS)

    European Heart Journal, Vol. 41, Núm. 4, pp. 543-603

  2. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review

    Journal of the American College of Cardiology, Vol. 75, Núm. 23, pp. 2950-2973

  3. Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: An international multicentre single-arm clinical trial

    European Heart Journal, Vol. 41, Núm. 4, pp. 509-518

  4. Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research

    Thrombosis and Haemostasis, Vol. 120, Núm. 7, pp. 1004-1024

2019

  1. The Prognostic Value of Renal Function in Acute Pulmonary Embolism - A Multi-Centre Cohort Study

    Thrombosis and Haemostasis, Vol. 119, Núm. 1, pp. 140-148

2018

  1. Differential impact of syncope on the prognosis of patients with acute pulmonary embolism: A systematic review and meta-analysis

    European Heart Journal, Vol. 39, Núm. 47, pp. 4186-4195

  2. Pulmonary embolism in Europe - Burden of illness in relationship to healthcare resource utilization and return to work

    Thrombosis Research, Vol. 170, pp. 181-191

2017

  1. Dabigatran after Short Heparin Anticoagulation for Acute Intermediate-Risk Pulmonary Embolism: Rationale and Design of the Single-Arm PEITHO-2 Study

    Thrombosis and Haemostasis, Vol. 117, Núm. 12, pp. 2425-2434

2015

  1. The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry

    Thrombosis Journal, Vol. 13, Núm. 1

  2. Validation of a model for identification of patients at intermediate to high risk for complications associated with acute symptomatic pulmonary embolism

    Chest, Vol. 148, Núm. 1, pp. 211-218

2014

  1. Derivation and validation of multimarker prognostication for normotensive patients with acute symptomatic pulmonary embolism

    American Journal of Respiratory and Critical Care Medicine, Vol. 189, Núm. 6, pp. 718-726

  2. Identification of intermediate-risk patients with acute symptomatic pulmonary embolism

    European Respiratory Journal, Vol. 44, Núm. 3, pp. 694-703

2013

  1. Response

    Chest